Tyra Biosciences (TYRA) Enterprise Value (2020 - 2026)
Tyra Biosciences (TYRA) posted Enterprise Value of -$85.0 million for Q1 2026, down 9.78% on a QoQ basis from -$77.4 million in Q4 2025, and up 15.65% year-over-year from -$73.5 million in Q1 2025.
Tyra Biosciences (TYRA) Enterprise Value (2020 - 2026) Analysis & Trends
Tyra Biosciences' Enterprise Value history runs 7 years deep, the most recent figure standing at -$85.0 million for Q1 2026.
- Quarterly Enterprise Value rose 15.65% year-over-year to -$85.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$85.0 million (up 15.65% YoY) and the FY2025 annual result came in at -$77.4 million, up 15.85% from the prior year.
- Enterprise Value was -$85.0 million for Q1 2026 at Tyra Biosciences, down from -$77.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$58.0 million in Q4 2023 and bottomed at -$292.5 million in Q1 2022.
- A 5-year average of -$164.9 million and a median of -$103.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 107.98% — and 2023, when it surged 76.91%.
- Tyra Biosciences' Enterprise Value stood at -$251.2 million in 2022, then jumped by 76.91% to -$58.0 million in 2023, then sank by 58.55% to -$92.0 million in 2024, then gained by 15.85% to -$77.4 million in 2025, then retreated by 9.78% to -$85.0 million in 2026.
- Business Quant data shows TYRA's Enterprise Value at -$85.0 million in Q1 2026, -$77.4 million in Q4 2025, and -$62.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | -84.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.96 Mn |
| Dec 31, 2025 | -77.39 Mn |
| Sep 30, 2025 | -61.95 Mn |
| Jun 30, 2025 | -98.49 Mn |
| Mar 31, 2025 | -100.72 Mn |
| Dec 31, 2024 | -91.97 Mn |
| Sep 30, 2024 | -103.89 Mn |
| Jun 30, 2024 | -99.49 Mn |
| Mar 31, 2024 | -254.37 Mn |
| Dec 31, 2023 | -58.01 Mn |
| Sep 30, 2023 | -215.65 Mn |
| Jun 30, 2023 | -232.41 Mn |
| Mar 31, 2023 | -241.70 Mn |
| Dec 31, 2022 | -251.21 Mn |
| Sep 30, 2022 | -263.21 Mn |
| Jun 30, 2022 | -275.11 Mn |
| Mar 31, 2022 | -292.50 Mn |
| Dec 31, 2021 | -302.18 Mn |
| Sep 30, 2021 | -312.82 Mn |
| Jun 30, 2021 | -135.20 Mn |